Provides second opinions for an applicant or an ethics committee, on a proposal that has been submitted for ethical review to an accredited ethics committee. Provides independent comment on ethical problems that may in health research. National Ethics Advisory Established under the New Provides advice to the Minister of Health on ethical issues in health Zealand Public Health and services and research. Committee (NEAC) Disability Act 2000. Determines national ethical standards across the health and disability sector. Members are appointed by the Minister of Health. Standing Committee on Established by the HRC. recommendations to the Director-General of Health on whether or Therapeutic Trials not clinical trials that involve the use of a new medicine should be approved. Assesses whether or not the proposed clinical of a medicine will provide clinically and scientifically useful information, particularly in relation to the safety and efficacy of the agent. Assesses the ability of the triallists to conduct the and attempts to improve design and the quality of clinical pharmacological research.
Provides second opinions for an applicant or an ethics committee, on a proposal that has been submitted for ethical review to an accredited ethics committee. Provides independent comment on ethical problems that may in health research. National Ethics Advisory Committee (NEAC) Established under the New Zealand Public Health and Disability Act 2000. Members are appointed by the Minister of Health. Provides advice to the Minister of Health on ethical issues in health services and research. Determines national ethical standards across the health and disability sector. Standing Committee on Therapeutic Trials Established by the HRC. recommendations to the Director-General of Health on whether or not clinical trials that involve the use of a new medicine should be approved. Assesses whether or not the proposed clinical of a medicine will provide clinically and scientifically useful information, particularly in relation to the safety and efficacy of the agent. Assesses the ability of the triallists to conduct the and attempts to improve design and the quality of clinical pharmacological research.
consultation-cross-sectoral-ethics-arrangements-health-disability-research.docx